ArticleFrontiers in microbiology2021
Isolation and Characterization of Potential
Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 34 citations in OpenAlex.
- Comprehensive Characterization of a Novel Broad-Host-Range LyticAntibiotics (Basel, Switzerland) · 2026Article
- Bacteriophages as Potential Sustainable Alternatives to Antibiotics for ControllingAntibiotics (Basel, Switzerland) · 2026Review
- Factors Influencing Biofilm Formation ofFoods (Basel, Switzerland) · 2026Article
- A new Epseptimavirus bacteriophage vB_SalS-SIY1lw as a potential antimicrobial alternative to multidrug-resistant Salmonella Infantis.Scientific reports · 2026Article
- Clonal and Plasmid-Mediated Dissemination of Multidrug-ResistantPathogens (Basel, Switzerland) · 2026Article
- A Tequintavirus bacteriophage SIA3lw isolated from sewage water with antimicrobial potential against antibiotic-resistant Salmonella Infantis.BMC microbiology · 2025Article
- Characterization and genome analysis of a novel lytic phage vB_ntSalS-cftriSP11 infecting Salmonella typhimurium.Molecular biology reports · 2025Article
- Efficiency, cytotoxicity, and survivability evaluation ofVeterinary world · 2025Article
- Characterization of an Indigenous Lytic Phage Targeting Multidrug-ResistantGut microbes reports · 2025Article
- Bacteriophages Against Bacterial Infections in Poultry Systems: A Scientometric Review.PHAGE (New Rochelle, N.Y.) · 2024Review
- Isolation, whole genome sequencing and application of a broad-spectrum Salmonella phage.Archives of microbiology · 2024Article
- Prevalence of Indigenous Antibiotic-Resistant Salmonella Isolates and Their Application to Explore a Lytic Phage vB_SalS_KFSSM with an Intra-Broad Specificity.Journal of microbiology (Seoul, Korea) · 2023Article
- Control ofFoods (Basel, Switzerland) · 2023Article
- A Bacteriophage Cocktail Reduces Five RelevantMicroorganisms · 2023Article
- Antibiofilm activity of a lytic Salmonella phage on different Salmonella enterica serovars isolated from broiler farms.International microbiology : the official journal of the Spanish Society for Microbiology · 2023Article
- Phenotypic Characterization and Comparative Genomic Analysis of NovelInternational journal of molecular sciences · 2023Article
- Isolation and characterization of phage ISTP3 for bio-control application against drug-resistantFrontiers in microbiology · 2023Article
- Oral Administration of a Phage Cocktail to ReduceAnimals : an open access journal from MDPI · 2022Article
- Broad lytic spectrum of novelVeterinary world · 2022Article
- Evolution of ß-lactams, fluroquinolones and colistin resistance and genetic profiles inItalian journal of food safety · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.